- Sections
- C - Chimiemétallurgie
- C07C - Composés acycliques ou carbocycliques
- C07C 311/46 - Y étant un atome d'hydrogène ou de carbone
Détention brevets de la classe C07C 311/46
Brevets de cette classe: 148
Historique des publications depuis 10 ans
|
9
|
14
|
12
|
8
|
8
|
13
|
13
|
6
|
6
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Corteva Agriscience LLC | 2629 |
10 |
| Vertex Pharmaceuticals Incorporated | 1578 |
5 |
| Stemsynergy Therapeutics, Inc. | 21 |
5 |
| Orsobio, Inc. | 19 |
5 |
| Bayer Pharma AG | 1002 |
4 |
| The University of Melbourne | 578 |
4 |
| Bristol-myers Squibb Company | 4751 |
3 |
| The General Hospital Corporation | 4903 |
3 |
| Northwestern University | 3593 |
3 |
| Dana-Farber Cancer Institute, Inc. | 2685 |
3 |
| The Scripps Research Institute | 1345 |
3 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3031 |
3 |
| Sanofi | 4338 |
3 |
| Vincere Biosciences, Inc. | 8 |
3 |
| F. Hoffmann-La Roche AG | 7784 |
2 |
| Duke University | 3192 |
2 |
| Baruch S. Blumberg Institute | 36 |
2 |
| Beth Israel Deaconess Medical Center, Inc. | 856 |
2 |
| Drexel University | 1000 |
2 |
| Icahn School of Medicine at Mount Sinai | 1062 |
2 |
| Autres propriétaires | 79 |